Robust data, supported by meta-analyses, indicate elevated levels of CXCL8/IL-8, CCL2/MCP-1, CCL4/MIP-1β, and CCL11/eotaxin-1 in the bloodstream of individuals with schizophrenia. This evidence concerns the gene CCL11 and schizophrenia.